Castle Biosciences, Inc.
CSTL
$21.98
$0.843.97%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 4.77% | 7.74% | 8.56% | -1.60% | 5.81% |
| Total Receivables | 1.90% | 9.29% | 7.70% | 11.48% | 3.51% |
| Inventory | 23.78% | -17.98% | 4.81% | -3.74% | 37.67% |
| Prepaid Expenses | -5.92% | 21.41% | 7.96% | -1.13% | -11.34% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 4.46% | 7.61% | 8.33% | 0.05% | 5.73% |
|
|
|||||
| Total Current Assets | 4.46% | 7.61% | 8.33% | 0.05% | 5.73% |
| Net Property, Plant & Equipment | 11.40% | 11.99% | 12.02% | 18.88% | 11.37% |
| Long-term Investments | 0.00% | 0.01% | -0.01% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.01% | -0.01% | 0.00% | 0.00% |
| Total Other Intangibles | -4.35% | -2.22% | -2.15% | -2.11% | -2.09% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -26.93% | -22.87% | 37.18% | 5.51% | -9.40% |
| Total Assets | 3.24% | 5.59% | 6.28% | 1.14% | 3.97% |
|
|
|||||
| Total Accounts Payable | 1.34% | -28.62% | 2.38% | -9.25% | 48.19% |
| Total Accrued Expenses | 10.25% | 26.56% | 34.07% | -41.32% | 26.61% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 17.13% | 42.33% | 3.11% | -1.57% | 10.72% |
| Total Finance Division Other Current Liabilities | 173.28% | -32.98% | 24.67% | -18.16% | 104.37% |
| Total Other Current Liabilities | 173.28% | -32.98% | 24.67% | -18.16% | 104.37% |
| Total Current Liabilities | 11.51% | 12.27% | 23.45% | -32.95% | 31.23% |
|
|
|||||
| Total Current Liabilities | 11.51% | 12.27% | 23.45% | -32.95% | 31.23% |
| Long-Term Debt | -2.70% | 0.07% | 0.08% | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -2.16% | 7.33% | 0.55% | -2.24% | 5.40% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -61.92% | -- | -- | 0.00% | -53.29% |
| Total Liabilities | 2.57% | 15.91% | 13.16% | -9.71% | 23.56% |
|
|
|||||
| Common Stock & APIC | 0.84% | 2.24% | 2.02% | 2.29% | 1.31% |
| Retained Earnings | 4.57% | 1.07% | 4.04% | -1.16% | -1.20% |
| Treasury Stock & Other | -51.37% | 375.00% | -54.95% | -181.62% | 291.55% |
| Total Common Equity | 3.35% | 4.05% | 5.32% | 2.86% | 1.42% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 3.35% | 4.05% | 5.32% | 2.86% | 1.42% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 3.35% | 4.05% | 5.32% | 2.86% | 1.42% |
|
|
|||||